{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:02:59Z","timestamp":1790730179320,"version":"4.1.0"},"reference-count":97,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T00:00:00Z","timestamp":1647648000000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>psychotropic medication use has been shown to increase with age and has been associated with increased risk of falls, strokes and mortality. Various guidelines, regulations and tools have been developed to reduce inappropriate prescribing, but this remains high. In order to understand the reasons for this, we aimed to systematically review healthcare professionals\u2019, patients\u2019 and family caregivers\u2019 attitudes towards the use of psychotropic medication in older people.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>a systematic literature search was carried out from inception to September 2020 using PUBMED, EMBASE, PsycINFO and CINAHL and hand-searching of reference lists. Included studies investigated stakeholder views on psychotropic in adults over the age of 65. Findings were thematically synthesised.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>overall, there was an acceptance of long-term psychotropic medication for older people both living in the community and in residential care. While healthcare professionals were aware of guidelines for the use of benzodiazepines and psychotropic medicines, they identified barriers to following them on individual, team and organisational levels. Alternative non-pharmacological approaches were not always available or accepted by patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>psychotropic medicine use in older adults remains a complex issue, which needs to be addressed on a broad level. Attitudes of older people and healthcare professionals encourage long-term use. Meanwhile, various internal and external factors act as barriers to the use of non-drug alternatives in this population. In order to reduce overprescribing of psychotropics, there is a need to increase the acceptability and accessibility of alternative interventions in both care homes and the community.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ageing\/afac060","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T20:10:48Z","timestamp":1646424648000},"source":"Crossref","is-referenced-by-count":18,"title":["Stakeholders\u2019 views on the use of psychotropic medication in older people: a systematic review"],"prefix":"10.1093","volume":"51","author":[{"given":"Eliza","family":"Bednarczyk","sequence":"first","affiliation":[{"name":"Research Department of Practice and Policy, School of Pharmacy, University College London (UCL), London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cook","sequence":"additional","affiliation":[{"name":"Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK"},{"name":"National Heart and Lung Institute, Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Brauer","sequence":"additional","affiliation":[{"name":"Research Department of Practice and Policy, School of Pharmacy, University College London (UCL), London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Garfield","sequence":"additional","affiliation":[{"name":"Research Department of Practice and Policy, School of Pharmacy, University College London (UCL), London, UK"},{"name":"Centre for Medication Safety and Service Quality, Imperial College Healthcare NHS Trust, London, UK"},{"name":"NIHR Imperial Patient Safety Translational Research Centre, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,19]]},"reference":[{"key":"2022031918044727400_ref1","volume-title":"First-Choice Antidepressant Use in Adults with Depression or Generalised Anxiety Disorder Key Therapeutic Topic [KTT8]","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"2022031918044727400_ref2","volume-title":"Antipsychotics in People Living with Dementia [KTT7]","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"2022031918044727400_ref3","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/bcp.14527","article-title":"A cross sectional study of psychotropic medicine use in Australia in 2018: a focus on polypharmacy","volume":"87","author":"Brett","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"2022031918044727400_ref4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/gps.1259","article-title":"Antidepressant drug prescribing among elderly subjects: a population-based study","volume":"20","author":"Percudani","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"2022031918044727400_ref5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1185\/135525705X40364","article-title":"Psychotropic prescribing for older people in residential care in the UK, are guidelines being followed?","volume":"10","author":"Dempsey","year":"2005","journal-title":"Prim Care Community Psychiatry"},{"key":"2022031918044727400_ref6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/ageing\/afaa122","article-title":"The burden of psychotropic and anticholinergic medicines use in care homes: population-based analysis in 147 care homes","volume":"50","author":"Grill","year":"2021","journal-title":"Age Ageing"},{"key":"2022031918044727400_ref7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1080\/13607863.2017.1348469","article-title":"Psychotropic drug prescription for nursing home residents with dementia: prevalence and associations with non-resident-related factors","volume":"22","author":"Smeets","year":"2018","journal-title":"Aging Ment Health"},{"key":"2022031918044727400_ref8","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1017\/S1041610216001150","article-title":"Psychotropic drug prescriptions in western European nursing homes","volume":"28","author":"Janus","year":"2016","journal-title":"Int Psychogeriatr"},{"key":"2022031918044727400_ref9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1440-0979.2003.00265.x","article-title":"Improving geriatric mental health nursing care: making a case for going beyond psychotropic medications","volume":"12","author":"Voyer","year":"2003","journal-title":"Int J Ment Health Nurs"},{"key":"2022031918044727400_ref10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/0898264320959293","article-title":"Patterns of psychoactive medication use in community-dwelling older adults in the US in 2016: a descriptive cross-sectional study","volume":"33","author":"Bajracharya","year":"2021","journal-title":"J Aging Health"},{"key":"2022031918044727400_ref11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00228-007-0422-1","article-title":"The clinical implications of ageing for rational drug therapy","volume":"64","author":"Shi","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"2022031918044727400_ref12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/0973-1229.58818","article-title":"The geriatric population and psychiatric medication","volume":"8","author":"Varma","year":"2010","journal-title":"Mens Sana Monogr"},{"key":"2022031918044727400_ref13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/gps.4483","article-title":"Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults","volume":"32","author":"Johnell","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"2022031918044727400_ref14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s41999-020-00376-1","article-title":"Polypharmacy, benzodiazepines, and antidepressants, but not antipsychotics, are associated with increased falls risk in UK care home residents: a prospective multi-Centre study","volume":"11","author":"Izza","year":"2020","journal-title":"Eur Geriatr Med"},{"key":"2022031918044727400_ref15","doi-asserted-by":"crossref","first-page":"371.e11","DOI":"10.1016\/j.jamda.2017.12.098","article-title":"Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics","volume":"19","author":"Seppala","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"2022031918044727400_ref16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40268-017-0181-0","article-title":"Psychotropic drug-related fall incidents in nursing home residents living in the eastern part of the Netherlands","volume":"17","author":"Janus","year":"2017","journal-title":"Drugs R&D"},{"key":"2022031918044727400_ref17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12916-020-01821-5","article-title":"Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study","volume":"18","author":"Richardson","year":"2020","journal-title":"BMC Med"},{"key":"2022031918044727400_ref18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.maturitas.2017.04.002","article-title":"Relationship between the use of benzodiazepines and falls in older adults: a systematic review","volume":"101","author":"D\u00edaz-Guti\u00e9rrez","year":"2017","journal-title":"Maturitas"},{"key":"2022031918044727400_ref19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jamda.2017.02.020","article-title":"Antipsychotics and the risk of cerebrovascular accident: a systematic review and meta-analysis of observational studies","volume":"18","author":"Hsu","year":"2017","journal-title":"J Am Med Dir Assoc"},{"key":"2022031918044727400_ref20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.38330.470486.8F","article-title":"Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study","volume":"330","author":"Gill","year":"2005","journal-title":"BMJ"},{"key":"2022031918044727400_ref21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12888-019-2177-5","article-title":"Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis","volume":"19","author":"Zivkovic","year":"2019","journal-title":"BMC Psychiatry"},{"key":"2022031918044727400_ref22","doi-asserted-by":"crossref","first-page":"e905","DOI":"10.4088\/JCP.16m10976","article-title":"Long-term antipsychotic use and major cardiovascular events: a retrospective cohort study","volume":"78","author":"Szmulewicz","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"2022031918044727400_ref23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm","volume":"72","author":"Maust","year":"2015","journal-title":"JAMA Psychiat"},{"key":"2022031918044727400_ref24","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"2022031918044727400_ref25","doi-asserted-by":"crossref","first-page":"e010662","DOI":"10.1136\/bmjopen-2015-010662","article-title":"Mortality and use of psychotropic medication in patients with stroke: a population-wide, register-based study","volume":"6","author":"Jennum","year":"2016","journal-title":"BMJ Open"},{"key":"2022031918044727400_ref26","volume-title":"Dementia: Assessment, Management and Support for People Living with Dementia and Their Carers NICE Guidance [NG97]","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"2022031918044727400_ref27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1176\/appi.ajp.2015.173501","article-title":"The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia","volume":"173","author":"Reus","year":"2016","journal-title":"Am J Psychiatry"},{"key":"2022031918044727400_ref28","first-page":"30","article-title":"The omnibus budget reconciliation act: impact on psychotropic drug use in long-term care facilities","volume":"31","author":"Keltner","year":"1995","journal-title":"Perspect Psychiatr Care"},{"key":"2022031918044727400_ref29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12877-019-1126-y","article-title":"Prevalence and persistent use of psychotropic drugs in older adults receiving domiciliary care at baseline","volume":"19","author":"Lornstad","year":"2019","journal-title":"BMC Geriatr"},{"key":"2022031918044727400_ref30","volume-title":"National Audit of Dementia: Prescription of Psychotropic Medication Initiated in Hospital for Behavioural and Psychological Symptoms of Dementia","author":"Royal College of Psychiatrists"},{"key":"2022031918044727400_ref31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/0101-60830000000089","article-title":"Patterns of chronic benzodiazepine use in the elderly","volume":"43","author":"Sgnaolin","year":"2016","journal-title":"Arch Clin Psychiatr"},{"key":"2022031918044727400_ref32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O'Mahony","year":"2015","journal-title":"Age Ageing"},{"key":"2022031918044727400_ref33","volume-title":"CCG7: Three High Impact Actions to Prevent Hospital Falls","author":"Commissioning for Quality and Innovation (CQUIN)"},{"key":"2022031918044727400_ref34","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","author":"American Geriatrics Society","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"2022031918044727400_ref35","volume-title":"DeprescribingTools","author":"New South Wales Therapeutic Advisory Group"},{"key":"2022031918044727400_ref36","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jamda.2018.05.002","article-title":"Antipsychotic deprescription for older adults in long-term care: the HALT study","volume":"19","author":"Brodaty","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"2022031918044727400_ref37","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2022031918044727400_ref38","first-page":"26","article-title":"An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project","volume":"22","author":"Breen","year":"2009","journal-title":"Int Psychogeriatr\/IPA"},{"key":"2022031918044727400_ref39","doi-asserted-by":"crossref","first-page":"e009882","DOI":"10.1136\/bmjopen-2015-009882","article-title":"Antipsychotic prescribing in care homes before and after launch of a national dementia strategy: an observational study in English institutions over a 4-year period","volume":"6","author":"Szczepura","year":"2016","journal-title":"BMJ Open"},{"key":"2022031918044727400_ref40","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jamda.2019.05.022","article-title":"When less is more, but still not enough: why focusing on limiting antipsychotics in people with dementia is the wrong policy imperative","volume":"20","author":"Kales","year":"2019","journal-title":"J Am Med Dir Assoc"},{"key":"2022031918044727400_ref41","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2022031918044727400_ref42","volume-title":"Older People: Independence and Mental Wellbeing NICE Guideline [NG32]","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"2022031918044727400_ref43","volume-title":"Doing Postgraduate Research","author":"City University of London"},{"key":"2022031918044727400_ref44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1176\/ajp.157.1.4","article-title":"Cholinesterase inhibitors: a new class of psychotropic compounds","volume":"157","author":"Cummings","year":"2000","journal-title":"Am J Psychiatry"},{"key":"2022031918044727400_ref45","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2753.2011.01662.x","article-title":"Reviewing studies with diverse designs: the development and evaluation of a new tool","volume":"18","author":"Sirriyeh","year":"2012","journal-title":"J Eval Clin Pract"},{"key":"2022031918044727400_ref46","volume-title":"Chapter 21: Qualitative Evidence","author":"Noyes"},{"key":"2022031918044727400_ref47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"2022031918044727400_ref48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"2022031918044727400_ref49","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/gps.5167","article-title":"Why deprescribing antipsychotics in older people with dementia in long-term care is not always successful: insights from the HALT study","volume":"34","author":"Aerts","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"key":"2022031918044727400_ref50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/09638230701677795","article-title":"Older primary care patient views regarding antidepressants: a mixed methods approach","volume":"18","author":"Bogner","year":"2009","journal-title":"J Ment Health"},{"key":"2022031918044727400_ref51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2850.2000.00356.x","article-title":"Medication compliance in older individuals with depression: gaining the views of family carers","volume":"7","author":"Boyle","year":"2000","journal-title":"J Psychiatr Ment Health Nurs (Wiley-Blackwell)"},{"key":"2022031918044727400_ref52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eurger.2013.11.005","article-title":"Barriers to discontinuation of chronic benzodiazepine use in nursing home residents: perceptions of general practitioners and nurses","volume":"5","author":"Bourgeois","year":"2014","journal-title":"Eur Geriatr Med"},{"key":"2022031918044727400_ref53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jamda.2005.05.005","article-title":"Wisdom from the front lines: clinicians\u2019 descriptions of treating agitation in the nursing home, a pilot study","volume":"6","author":"Cohen-Mansfield","year":"2005","journal-title":"J Am Med Dir Assoc"},{"key":"2022031918044727400_ref54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11606-006-0021-3","article-title":"Physicians\u2019 perspectives on prescribing benzodiazepines for older adults: a qualitative study","volume":"22","author":"Cook","year":"2007","journal-title":"Soc Gen Intern Med"},{"key":"2022031918044727400_ref55","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s11606-007-0205-5","article-title":"Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study","volume":"22","author":"Cook","year":"2007","journal-title":"Soc Gen Intern Med"},{"key":"2022031918044727400_ref56","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.3399\/bjgp10X483913","article-title":"Long-term prescribing of antidepressants in the older population: a qualitative study","volume":"60","author":"Dickinson","year":"2010","journal-title":"Br J Gen Pract"},{"key":"2022031918044727400_ref57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.colegn.2012.02.003","article-title":"The management of behavioural problems associated with dementia in rural aged care","volume":"19","author":"Ervin","year":"2012","journal-title":"Collegian"},{"key":"2022031918044727400_ref58","first-page":"81","article-title":"Antidepressant use in older people: family physicians' knowledge, attitudes, and practices","volume":"51","author":"Fitch","year":"2005","journal-title":"Can Fam Physician"},{"key":"2022031918044727400_ref59","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jaging.2012.07.001","article-title":"\u201cAnd mostly they have a need for sleeping pills\u201d: Physicians' views on treatment of sleep disorders with drugs in nursing homes","volume":"26","author":"Flick","year":"2012","journal-title":"J Aging Stud"},{"key":"2022031918044727400_ref60","first-page":"146","article-title":"Older Patients' aversion to antidepressants: a qualitative study","volume":"21","author":"Givens","year":"2006","journal-title":"J Gen Intern Med"},{"key":"2022031918044727400_ref61","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/geront\/28.5.667","article-title":"Attitudes and knowledge of gerontological nurses toward psychotropic drugs","volume":"28","author":"Glasspoole","year":"1988","journal-title":"Gerontologist"},{"key":"2022031918044727400_ref62","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/02813432.2011.628240","article-title":"Treatment decisions on antidepressants in nursing homes: a qualitative study","volume":"29","author":"Iden","year":"2011","journal-title":"Scand J Prim Health Care"},{"key":"2022031918044727400_ref63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/089198879400700309","article-title":"Psychoactive medications in the long-term care setting: differing perspectives among physicians, nursing staff, and patients","volume":"7","author":"Jacobson","year":"1994","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2022031918044727400_ref64","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1017\/S1041610216001897","article-title":"Determinants of the nurses' and nursing assistants' request for antipsychotics for people with dementia","volume":"29","author":"Janus","year":"2017","journal-title":"Int Psychogeriatr"},{"key":"2022031918044727400_ref65","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1093\/geront\/gnx042","article-title":"Caregiver perspectives about using antipsychotics and other medications for symptoms of dementia","volume":"58","author":"Kerns","year":"2018","journal-title":"Gerontologist"},{"key":"2022031918044727400_ref66","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/13607860500310633","article-title":"Elderly depressed patients: what are their views on treatment options?","volume":"10","author":"Kuruvilla","year":"2006","journal-title":"Aging Ment Health"},{"key":"2022031918044727400_ref67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2648.2006.03893.x","article-title":"Use of major and minor tranquilizers with older patients in an acute care hospital: an exploratory study","volume":"55","author":"Kwasny","year":"2006","journal-title":"J Adv Nurs"},{"key":"2022031918044727400_ref68","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jamda.2013.08.009","article-title":"Knowledge of and perceived need for evidence-based education about antipsychotic medications among nursing home leadership and staff","volume":"14","author":"Lemay","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"2022031918044727400_ref69","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1017\/S1041610215000216","article-title":"Beliefs about antidepressants among persons aged 70 years and older in treatment after a suicide attempt","volume":"27","author":"Les\u00e9n","year":"2015","journal-title":"Int Psychogeriatr"},{"key":"2022031918044727400_ref70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/inm.12181","article-title":"Beliefs about antidepressant medication and associated adherence among older Chinese patients with major depression: a cross-sectional survey","volume":"25","author":"Lu","year":"2016","journal-title":"Int J Ment Health Nurs"},{"key":"2022031918044727400_ref71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00048679009062888","article-title":"Can overuse of psychotropic drugs by the elderly be prevented?","volume":"24","author":"Lyndon","year":"1990","journal-title":"Aust N Z J Psychiatry"},{"key":"2022031918044727400_ref72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1300\/J018v13n01_03","article-title":"Attitudes and knowledge of long term care nurses toward psychotropic medication for the elderly","volume":"13","author":"Mort","year":"1993","journal-title":"Clin Gerontol"},{"key":"2022031918044727400_ref73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/0891988708316862","article-title":"Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study","volume":"21","author":"Oehlberg","year":"2008","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2022031918044727400_ref74","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/08952841.2011.611070","article-title":"Chronic psychotropic drug use among frail elderly women receiving home care services","volume":"23","author":"P\u00e9rodeau","year":"2011","journal-title":"J Women Aging"},{"key":"2022031918044727400_ref75","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0165-0327(01)00315-9","article-title":"What are older people's experiences of taking antidepressants?","volume":"70","author":"Prabhakaran","year":"2002","journal-title":"J Affect Disord"},{"key":"2022031918044727400_ref76","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1017\/S1041610215002380","article-title":"Attitudes towards pharmacotherapy in late-life bipolar disorder","volume":"28","author":"Rej","year":"2016","journal-title":"Int Psychogeriatr"},{"key":"2022031918044727400_ref77","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40801-016-0066-5","article-title":"Prescribing of psychoactive drugs for older people in nursing homes: an analysis of treatment culture","volume":"3","author":"Shaw","year":"2016","journal-title":"Drugs Real World Outcomes"},{"key":"2022031918044727400_ref78","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1176\/appi.ps.52.5.666","article-title":"Variations in the treatment culture of nursing homes and responses to regulations to reduce drug use","volume":"52","author":"Svarstad","year":"2001","journal-title":"Psychiatr Serv"},{"key":"2022031918044727400_ref79","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1741-6612.2008.00308.x","article-title":"Antipsychotic use in the elderly: what doctors say they do, and what they do","volume":"27","author":"Tiller","year":"2008","journal-title":"Australas J Ageing"},{"key":"2022031918044727400_ref80","doi-asserted-by":"crossref","DOI":"10.1111\/jocn.15477","article-title":"Exploring acute care nurses' decision-making in psychotropic PRN use in hospitalised people with dementia","author":"Walsh","year":"2020","journal-title":"J Clin Nurs"},{"key":"2022031918044727400_ref81","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jamda.2018.07.004","article-title":"Exploring antipsychotic prescribing behaviors for nursing home residents with dementia: a qualitative study","volume":"19","author":"Walsh","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"2022031918044727400_ref82","first-page":"143","article-title":"Prescribing psychotropic medication for elderly patients: some physicians' perspectives","volume":"161","author":"Damestoy","year":"1999","journal-title":"CMAJ"},{"key":"2022031918044727400_ref83","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1186\/s12889-020-08984-z","article-title":"Trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs in the health region of Lleida from 2002 to 2015","volume":"20","author":"Torres-Bondia","year":"2020","journal-title":"BMC Public Health"},{"key":"2022031918044727400_ref84","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12888-017-1254-x","article-title":"Changes in prevalence of psychotropic drug use and alcohol consumption among the elderly in Germany: results of two National Health Interview and examination surveys 1997\u201399 and 2008\u201311","volume":"17","author":"Wolf","year":"2017","journal-title":"BMC Psychiatry"},{"key":"2022031918044727400_ref85","doi-asserted-by":"crossref","first-page":"e200029","DOI":"10.1590\/1980-549720200029","article-title":"Aumento da utiliza\u00e7\u00e3o de benzodiazep\u00ednicos entre idosos mais velhos: Projeto Bambu\u00ed","volume":"23","author":"Oliveira","year":"2020","journal-title":"Rev Bras Epidemiol"},{"key":"2022031918044727400_ref86","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.4088\/JCP.16m10713","article-title":"National trends in antidepressant, benzodiazepine, and other sedative-hypnotic treatment of older adults in psychiatric and primary care","volume":"78","author":"Maust","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"2022031918044727400_ref87","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12877-021-02213-x","article-title":"The prevalence and prescribing patterns of benzodiazepines and Z-drugs in older nursing home residents in different European countries and Israel: retrospective results from the EU SHELTER study","volume":"21","author":"Luka\u010di\u0161inov\u00e1","year":"2021","journal-title":"BMC Geriatr"},{"key":"2022031918044727400_ref88","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1093\/geront\/gnx014","article-title":"Self-perceptions of aging and perceived barriers to care: reasons for health care delay","volume":"57","author":"Sun","year":"2017","journal-title":"Gerontologist"},{"key":"2022031918044727400_ref89","first-page":"408","article-title":"Short-term buffers, but long-term suffers? Differential effects of negative self-perceptions of aging following serious health events","volume":"72","author":"Wolff","year":"2017","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"2022031918044727400_ref90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1037\/pag0000061","article-title":"Negative perceptions of aging predict longitudinal decline in cognitive function","volume":"31","author":"Robertson","year":"2016","journal-title":"Psychol Aging"},{"key":"2022031918044727400_ref91","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/pds.4142","article-title":"Trends in potentially inappropriate medication prescribing to nursing home patients: comparison of three cross-sectional studies","volume":"26","author":"Halvorsen","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022031918044727400_ref92","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(96)90538-3","article-title":"Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews","volume":"347","author":"Moher","year":"1996","journal-title":"Lancet"},{"key":"2022031918044727400_ref93","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1017\/S0266462312000086","article-title":"The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies","volume":"28","author":"Morrison","year":"2012","journal-title":"Int J Technol Assess Health Care"},{"key":"2022031918044727400_ref94","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.11124\/JBIES-20-00361","article-title":"Language bias in systematic reviews: you only get out what you put in","volume":"18","author":"Stern","year":"2020","journal-title":"JBI Evid Synth"},{"key":"2022031918044727400_ref95","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13643-018-0786-6","article-title":"The prevalence of and factors associated with inclusion of non-English language studies in Campbell systematic reviews: a survey and meta-epidemiological study","volume":"7","author":"Neimann Rasmussen","year":"2018","journal-title":"Syst Rev"},{"key":"2022031918044727400_ref96","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1176\/appi.ajp.2015.15010130","article-title":"Impact of antipsychotic review and nonpharmacological intervention on antipsychotic use, neuropsychiatric symptoms, and mortality in people with dementia living in nursing homes: a factorial cluster-randomized controlled trial by the well-being and health for people with dementia (WHELD) program","volume":"173","author":"Ballard","year":"2016","journal-title":"Am J Psychiatry"},{"key":"2022031918044727400_ref97","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12877-018-1015-9","article-title":"Consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients","volume":"19","author":"Massot Mesquida","year":"2019","journal-title":"BMC Geriatr"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/51\/3\/afac060\/42955155\/afac060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/51\/3\/afac060\/42955155\/afac060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T18:05:36Z","timestamp":1647713136000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afac060\/6550831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afac060","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2022,3,1]]},"article-number":"afac060"}}